BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32321809)

  • 21. Nipah virus attachment glycoprotein ectodomain delivered by type 5 adenovirus vector elicits broad immune response against NiV and HeV.
    Huang X; Li Y; Li R; Wang S; Yang L; Wang S; Yin Y; Zai X; Zhang J; Xu J
    Front Cell Infect Microbiol; 2023; 13():1180344. PubMed ID: 37577376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.
    Sawatsky B; Grolla A; Kuzenko N; Weingartl H; Czub M
    J Gen Virol; 2007 Feb; 88(Pt 2):582-591. PubMed ID: 17251577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.
    Ciancanelli MJ; Volchkova VA; Shaw ML; Volchkov VE; Basler CF
    J Virol; 2009 Aug; 83(16):7828-41. PubMed ID: 19515782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses.
    Zhu W; Smith G; Pickering B; Banadyga L; Yang M
    Viruses; 2024 May; 16(5):. PubMed ID: 38793674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of truncated phosphoproteins of Nipah virus and Hendra virus in Escherichia coli for the differentiation of henipavirus infections.
    Chen JM; Yaiw KC; Yu M; Wang LF; Wang QH; Crameri G; Wang ZL
    Biotechnol Lett; 2007 Jun; 29(6):871-5. PubMed ID: 17322967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Henipavirus infection by RNA interference.
    Mungall BA; Schopman NC; Lambeth LS; Doran TJ
    Antiviral Res; 2008 Dec; 80(3):324-31. PubMed ID: 18687361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace's line a barrier to Nipah virus?
    Breed AC; Meers J; Sendow I; Bossart KN; Barr JA; Smith I; Wacharapluesadee S; Wang L; Field HE
    PLoS One; 2013; 8(4):e61316. PubMed ID: 23637812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudotyped Virus for Henipavirus.
    Li T; Liang Z; Huang W; Wang Y
    Adv Exp Med Biol; 2023; 1407():175-190. PubMed ID: 36920697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2.
    Lieu KG; Marsh GA; Wang LF; Netter HJ
    Antiviral Res; 2015 Dec; 124():69-76. PubMed ID: 26526590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
    Amaya M; Yin R; Yan L; Borisevich V; Adhikari BN; Bennett A; Malagon F; Cer RZ; Bishop-Lilly KA; Dimitrov AS; Cross RW; Geisbert TW; Broder CC
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
    Negrete OA; Chu D; Aguilar HC; Lee B
    J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Henipaviruses: an expanding global public health concern?
    Quarleri J; Galvan V; Delpino MV
    Geroscience; 2022 Oct; 44(5):2447-2459. PubMed ID: 36219280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review.
    Bhattacharya S; Dhar S; Banerjee A; Ray S
    Curr Mol Pharmacol; 2020; 13(2):108-125. PubMed ID: 31657692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hendra and Nipah viruses: different and dangerous.
    Eaton BT; Broder CC; Middleton D; Wang LF
    Nat Rev Microbiol; 2006 Jan; 4(1):23-35. PubMed ID: 16357858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hendra virus and Nipah virus animal vaccines.
    Broder CC; Weir DL; Reid PA
    Vaccine; 2016 Jun; 34(30):3525-34. PubMed ID: 27154393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cedar virus: a novel Henipavirus isolated from Australian bats.
    Marsh GA; de Jong C; Barr JA; Tachedjian M; Smith C; Middleton D; Yu M; Todd S; Foord AJ; Haring V; Payne J; Robinson R; Broz I; Crameri G; Field HE; Wang LF
    PLoS Pathog; 2012; 8(8):e1002836. PubMed ID: 22879820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular virology of the henipaviruses.
    Rota PA; Lo MK
    Curr Top Microbiol Immunol; 2012; 359():41-58. PubMed ID: 22552699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
    Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
    J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.